MindWalk Holdings Corp. (HYFT)
NASDAQ: HYFT · Real-Time Price · USD
1.500
-0.030 (-1.96%)
At close: Jun 22, 2026, 4:00 PM EDT
1.520
+0.020 (1.33%)
After-hours: Jun 22, 2026, 6:30 PM EDT
MindWalk Holdings Revenue
MindWalk Holdings had revenue of 4.16M CAD in the quarter ending January 31, 2026, with 52.42% growth. This brings the company's revenue in the last twelve months to 18.42M, up 28.49% year-over-year. In the fiscal year ending April 30, 2025, MindWalk Holdings had annual revenue of 24.52M with 0.01% growth.
Revenue (ttm)
18.42M CAD
Revenue Growth
+28.49%
P/S Ratio
3.53
Revenue / Employee
180,627 CAD
Employees
102
Market Cap
74.50M USD
Revenue Chart
* This company reports financials in CAD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Apr 30, 2025 | 24.52M | 2.00K | 0.01% |
| Apr 30, 2024 | 24.52M | 3.85M | 18.65% |
| Apr 30, 2023 | 20.67M | 1.30M | 6.72% |
| Apr 30, 2022 | 19.36M | 1.45M | 8.11% |
| Apr 30, 2021 | 17.91M | 3.85M | 27.41% |
| Apr 30, 2020 | 14.06M | 3.13M | 28.66% |
| Apr 30, 2019 | 10.93M | 5.48M | 100.80% |
| Apr 30, 2018 | 5.44M | 2.81M | 106.85% |
| Apr 30, 2017 | 2.63M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionHYFT News
- 10 days ago - MindWalk (NASDAQ: HYFT) CEO Dr. Jennifer Bath to Join Absci (NASDAQ: ABSI) and a Leading AI Compute Provider on Jones AI Day Panel on the Future of AI Drug Discovery - Business Wire
- 12 days ago - MindWalk launches ReefIQ context layer - TheFly
- 12 days ago - MindWalk Holdings Corp. (NASDAQ: HYFT) Launches ReefIQ™, a Biological Context Layer for AI Drug Discovery - Business Wire
- 20 days ago - MindWalk says preclinical dengue data support HYFT computational prediction - TheFly
- 20 days ago - MindWalk's Preclinical Dengue Data Support a HYFT® Computational Prediction: Immunogens Designed on the Predicted Target Elicited Cross-Reactive Antibodies Against Antigens of All Four Dengue Serotypes, Reproduced Across Two Independent Campaigns - Business Wire
- 26 days ago - MindWalk announces launch of Pandemic Response Platform - TheFly
- 26 days ago - MindWalk Holdings Deploys Pandemic Response Platform via HYFT® Technology as Ebola and Hantavirus Outbreaks Expose the Limits of Strain-Specific Coverage - Business Wire
- 5 weeks ago - MindWalk identifies over 20 partner-owned drug programs reaching clinical trials - TheFly